U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.7806G>A (p.Trp2602Ter) AND Marfan syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 18, 2011
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000029781.1

Allele description

NM_000138.5(FBN1):c.7806G>A (p.Trp2602Ter)

Gene:
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.7806G>A (p.Trp2602Ter)
Other names:
p.W2602X:TGG>TGA
HGVS:
  • NC_000015.10:g.48420700C>T
  • NG_008805.2:g.230089G>A
  • NM_000138.5:c.7806G>AMANE SELECT
  • NP_000129.3:p.Trp2602Ter
  • NP_000129.3:p.Trp2602Ter
  • LRG_778t1:c.7806G>A
  • LRG_778:g.230089G>A
  • LRG_778p1:p.Trp2602Ter
  • NC_000015.9:g.48712897C>T
  • NM_000138.4:c.7806G>A
  • p.Trp2602X
Protein change:
W2602*
Links:
dbSNP: rs193922236
NCBI 1000 Genomes Browser:
rs193922236
Molecular consequence:
  • NM_000138.5:c.7806G>A - nonsense - [Sequence Ontology: SO:0001587]
Observations:
2

Condition(s)

Name:
Marfan syndrome (MFS)
Synonyms:
MARFAN SYNDROME, TYPE I; Marfanoid hypermobility syndrome; Marfan syndrome type 1; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007947; MedGen: C0024796; Orphanet: 284963; Orphanet: 558; OMIM: 154700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000052435Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
likely pathogenic
(Aug 18, 2011)
germlinecuration, clinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown2not providednot providednot providednot providedclinical testing
not providedgermlineyes1not providednot providednot providednot providedcuration

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000052435.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided
2not providednot providednot providednot providedclinical testingnot provided
3not providednot providednot providednot providedclinical testingnot provided

Description

Converted during submission to Likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providedBloodassert pathogenicitynot providednot providednot providednot provided
2germlineunknownnot providedBloodassert pathogenicitynot providednot providednot provided See 2
3germlineunknownnot providedBloodassert pathogenicitynot providednot providednot providednot provided

Co-occurrences

#ZygosityAllelesNumber of Observations
2SingleHeterozygoteFBN1:c.6997+17C>G, FBN1:c.3464-5G>A, FBN1:c.1875T>C, FBN1:c.1415G>A, FBN1:c.7230C>T1

Last Updated: Feb 26, 2022